Ali Health has officially launched its medical AI assistant named "Hydrogen Ion" and announced an exclusive content partnership with the UK-based BMJ Group. This collaboration signifies the beginning of Ali Health's cooperation with top-tier international medical journals. Hydrogen Ion revealed it is currently in communication with multiple leading global journals regarding further partnerships.
At the launch event, Ali Health stated that Hydrogen Ion aims to be a more reliable medical AI assistant by excelling in three dimensions: "top-tier medical evidence", "evidence-based medicine", and "AI capabilities". It directly connects to the highest-quality evidence sources from leading domestic and international journals to help Chinese doctors solve medical problems.
Under the exclusive content agreement, BMJ Group will grant Hydrogen Ion exclusive access to the content and multimedia resources published over the past decade across its 70 medical journals. This makes Hydrogen Ion BMJ Group's exclusive medical AI platform partner in China. Consequently, Chinese doctors will be able to use Hydrogen Ion to directly access global top-tier medical literature for evidence-based Q&A, full-text reading, and online translation, aiding in clinical practice and scientific research.
Regarding the partnership, Niels Peter Thomas, CEO of BMJ Group's Publishing division, commented: "BMJ Group is dedicated to providing high-quality medical knowledge and promoting global health. Integrating our journal content into the AI medical platform 'Hydrogen Ion' represents an innovative step beyond traditional knowledge access methods. We look forward to better and more extensively serving Chinese doctors through this initiative."
Shen Difan, Chairman of the Board and CEO of Ali Health, stated: "Ali Health is honored to collaborate with BMJ Group to infuse global top-tier medical wisdom into 'Hydrogen Ion'. This marks a crucial step in our journey to build an AI assistant characterized by 'low hallucination and high evidence-based' standards, providing Chinese doctors with the most trustworthy decision-making support."
Previously, Hydrogen Ion has established deep collaborations with several authoritative domestic academic institutions, including the Chinese Medical Association, People's Medical Publishing House, and the Chinese Anti-Cancer Association (CACA).
In the areas of evidence-based medicine and AI capabilities, Hydrogen Ion announced the establishment of a "Medical AI Expert Committee" at the event, inviting over 300 Chinese clinical experts to jointly develop medical AI evaluation standards and datasets.
Furthermore, Ali Health's CTO Wang Xiangzhi unveiled the four-layer evidence-based AI architecture of Hydrogen Ion. The first layer is Evidence Understanding and Content System, where all guidelines and literature are structured for understanding based on the PICO framework and GRADE standards upon entry into the system. The second layer involves PICO-based Retrieval and Data Enhancement, ensuring every statement in the output is traceable to a source. The third layer is Model Reinforcement and Fine-tuning, teaching the model "what constitutes an accurate, faithfully evidence-based, safe, and useful answer" and ensuring it meets the stringent standards of evidence-based medicine. The fourth layer is the Medical Expert Review System, which completes the quality feedback loop.